September 22, 2025

Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain health diseases, excluding the Republic of Korea, China, Hong Kong, Macau and Taiwan Sovargen receives upfront payment and is eligible for future milestone-dependent payments and

FORT WASHINGTON, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) — Coventry, the leader and creator of the secondary market for life insurance, is proud to recognize Life Insurance Awareness Month by reaffirming its unwavering commitment to making life insurance not just an essential asset, but also more valuable, more flexible and

Governing Board approves major financing package as institution launches inaugural Euro benchmark bond OPEC Fund President Abdulhamid Alkhalifa VIENNA, Sept. 22, 2025 (GLOBE NEWSWIRE) — The OPEC Fund for International Development (the OPEC Fund) announced the approval of more than US$1 billion in new development financing during the 193rd meeting